目录号 | 产品详情 | 靶点 | |
---|---|---|---|
T70155 | |||
Fenoldopam hydrochloride is a selective D1-like dopamine receptor partial agonist. It acts as a vasodilator in vivo and does not readily cross the blood-brain barrier. Fenoldopam HCl is also an α2-adrenoceptor antagonist in vitro. | |||
T60304 | |||
(E)-Guanabenz ((E)-Wy-8678) 是一种具有口服活性的中枢α2-肾上腺素受体 (α2-adrenoceptor)激动剂。(E)-Guanabenz 具有抗高血压活性,通过刺激中枢 α2- 肾上腺素受体,并减少交感神经向外周的净流出而起作用。(E)-Guanabenz z 也直接结合并抑制 GADD34,具有神经保护活性。(E)-Guanabenz 可用于研究高血压和帕金森病。 | |||
T21492 | |||
Medetomidine(Domtor)是一种有效的、高选择性的、具有口服活性的α2肾上腺素受体激动剂,对α2和α1肾上腺素受体的 Ki 值分别为1.08 nM 和1750 nM。 | |||
T60548 | |||
Guanoxabenz (Hydroxyguanabenz) hydrochloride 是 α2 肾上腺素能受体的激动剂,Ki 值为 4000 nM,对 α2A 肾上腺素受体完全激活形式的Ki 值为 40 nM。 | |||
TN2267 | Adrenergic Receptor | ||
Tetrahydroalstonine 是从 Rhazya stricta 的果实中提取出来的吲哚类生物碱,是一种具有选择性的 α2-肾上腺素受体拮抗剂。Tetrahydroalstonine 在Rauwolfia tetraphylla 中表现出抗精神病活性。 | |||
T16759 | Dopamine Receptor 5-HT Receptor Adrenergic Receptor Histamine Receptor | ||
Ritanserin (R 55667) 是一种长效、高效、相对选择性、可口服的5-HT2受体拮抗剂,IC50值为 0.9 nM。 | |||
T23396 | 5-HT Receptor | ||
ST1936 (ST 1936 oxalate) 是一种具有选择性和高效性的 5-HT6 受体激动剂,抑制人 5-HT6、5-HT7 和 5-HT2B 受体,通过完全激活克隆的人 5-HT6 受体来刺激 cAMP、Ca2+、ERK1/2 和 Fyn 激酶。 | |||
T21911 | Apoptosis Imidazoline Receptor | ||
Rilmenidine hemifumarate (S-3341 hemifumarate) 是一种新型且具有口服活性和选择性 的 I1咪唑啉受体 (I1 imidazoline receptor) 和α2肾上腺素受体激动剂,可诱导自噬 ,调节白血病细胞增殖,刺激促凋亡蛋白 Bax,诱导人白血病 K562 细胞线粒体通路的紊乱和凋亡。 | |||
TCS2185 | Adrenergic Receptor | ||
Yohimbine 是一种有效的、相对非选择性的α2 - 肾上腺素能受体拮抗剂,IC50=0.6μM。 |
目录号 | 产品名/同用名 | 种属 | 表达系统 | ||
---|---|---|---|---|---|
TMPK-01523 | Chimeric HLA-A*02:01 (mα3) &B2M&WT-1 (RMFPNAPYL) Monomer Protein, Human&Mouse, MHC (His & Avi) | Human & Mouse | HEK293 Cells | ||
The WT1 protein plays a role in cell growth, the process by which cells mature to perform specific functions (differentiation), and the self-destruction of cells (apoptosis). WT1 is differentially expressed in serous, endometrioid, clear cell, and mucinous carcinomas of the peritoneum, fallopian tube, ovary, and endometrium.The Human HLA-A*0201 WT-1 (RMFPNAPYL) complex Protein is a complex of HLA-A*0201 of the MHC Class I, B2M and RMFPNAPYL peptide of the WT-1.
|
|||||
TMPK-01534 | Chimeric HLA-A*02:01 (mα3) &B2M&LMP2 (CLGGLLTMV) Monomer Protein, Human&Mouse, MHC (His & Avi) | Human & Mouse | HEK293 Cells | ||
The immunoproteasome, having been linked to neurodegenerative diseases and hematological cancers, has been shown to play an important role in MHC class I antigen presentation. The development of molecular probes that selectively inhibit the major catalytic subunit, LMP2, of the immunoproteasome,LMP2-rich cancer cells compared to LMP2-deficient cancer cells are more sensitive to growth inhibition by the LMP2-specific inhibitor, implicating an important role of LMP2 in regulating cell growth of malignant tumors that highly express LMP2.
|
|||||
TMPK-01522 | Chimeric HLA-A*02:01 (mα3) &B2M&WT-1 (RMFPNAPYL) Tetramer Protein, Human&Mouse, MHC (His & Avi) | Human & Mouse | HEK293 Cells | ||
The WT1 protein plays a role in cell growth, the process by which cells mature to perform specific functions (differentiation), and the self-destruction of cells (apoptosis). WT1 is differentially expressed in serous, endometrioid, clear cell, and mucinous carcinomas of the peritoneum, fallopian tube, ovary, and endometrium.The Human HLA-A*0201 WT-1 (RMFPNAPYL) complex Protein is a complex of HLA-A*0201 of the MHC Class I, B2M and RMFPNAPYL peptide of the WT-1.
|
|||||
TMPK-01535 | Chimeric HLA-A*02:01 (mα3) &B2M&LMP2 (CLGGLLTMV) Tetramer Protein, Human&Mouse, MHC (His & Avi) | Human & Mouse | HEK293 Cells | ||
The immunoproteasome, having been linked to neurodegenerative diseases and hematological cancers, has been shown to play an important role in MHC class I antigen presentation. The development of molecular probes that selectively inhibit the major catalytic subunit, LMP2, of the immunoproteasome,LMP2-rich cancer cells compared to LMP2-deficient cancer cells are more sensitive to growth inhibition by the LMP2-specific inhibitor, implicating an important role of LMP2 in regulating cell growth of malignant tumors that highly express LMP2.
|